Impact of 2004 ISUP/WHO classification on bladder cancer grading

World Journal of Urology

Volumn 33, Issue 12, 2015, Pages 1929-1936

  Lokeshwar, Soum D ^a   Ruiz Cordero, Roberto ^b   Hupe, Marie C ^c   Jorda, Merce ^b   Soloway, Mark S ^d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Hollywood Memorial Hospital   (United States)

Author keywords

1998 WHO ISUP grading; 2004 WHO grading; Bladder cancer; Progression

Indexed keywords

AGED; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CLASSIFICATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MEDICAL SOCIETY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; URINARY BLADDER NEOPLASMS;

EID: 84947616045     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1548-x     Document Type: Article

References (30)

1. Jordan AM, Weingarten J, Murphy WM (1987) Transitional cell neoplasms of the urinary bladder: can biologic potential be predicted from histologic grading? Cancer 60:2766–2774. Erratum: (1988) Cancer 61:1385
2. Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers. Eur Urol 63:4–15. doi:10.1016/j.eururo.2012.09.057
3. Pezaro C, Liew MS, Davis ID (2012) Urothelial cancers: using biology to improve outcomes. Expert Rev Anticancer Ther 12:87–98. doi:10.1586/era.11.195
4. Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: pathology. Eur Urol 63:16–35. doi:10.1016/j.eururo.2012.09.063
5. Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thürof J, Witjes JA, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 63:36–44. doi:10.1016/j.eururo.2012.08.061
6. Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagalowsky AI, Soloway MS, Stenzl A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 63:45–57. doi:10.1016/j.eururo.2012.08.009
7. Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS (2013) Recent advances in the diagnosis and treatment of bladder cancer. BMC Med 11:13. doi:10.1186/1741-7015-11-13
8. Weizer AZ, Tallman C, Montgomery JS (2011) Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer. World J Urol 29:59–71. doi:10.1007/s00345-010-0617-4
9. Rodriguez Faba O, Gaya JM, López JM, Capell M, De Gracia-Nieto AE, Gomez Correa E, Breda A, Palou J (2013) Current management of non-muscle-invasive bladder cancer. Minerva Med 104:273–286
10. Gandhi NM, Morales A, Lamm DL (2013) Bacillus Calmette-Guerin immunotherapy for genitourinary cancer. BJU Int 112:288–297. doi:10.1111/j.1464-410X.2012.11754.x
11. Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ (2013) Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int 112:13–25. doi:10.1111/j.1464-410X.2012.11762.x
12. Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical–pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 130:371–378
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22:1435–1448
14. Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S (2011) The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int 107:404–408. doi:10.1111/j.1464-410X.2010.09515.x
15. Amin MB, Reuter VE, Epstein J, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R, Paner GP, Soloway M, Members of the Pathology of Bladder Cancer Working group (2012) Pathology consensus guidelines by the pathology of bladder cancer work group. In: Soloway MS, Khoury S (eds) Bladder Cancer, 2nd International Consultation on Bladder Cancer, 2nd edn., pp 63–168
16. Reuter VE, Epstein JI, Amin MB, Mostofi FK (1999) The “WHO/ISUP consensus classification of urothelial (transitional cell) neoplasms”: continued discussion. Hum Pathol 30:879–880
17. Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI (2010) Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol Int 60:1–8. doi:10.1111/j.1440-1827.2009.02477.x
18. Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW, Hudson MA (2010) Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76:593–599. doi:10.1016/j.urology.2010.01.032
19. May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Guina S (2010) Prognostic accuracy of individual pathologists in noninvasive urinary bladder carcinoma a multicenter study comparing the 1973 and 2004 World Health Organisation Classifications. Eur Urol 57:850–858. doi:10.1016/j.eururo.2009.03
20. Burger M, Denzinger S, Wieland WF, Stief GC, Hartmann A, Zaak D (2008) Does the current World Health Organization classification predict outcome better in patients with noninvasive bladder cancer of early or regular onset? BJU Int 102:194–197. doi:10.1111/j.1464-410X.2008.07538.x
21. Yin H, Leong AS (2004) Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISIP system by immunophenotyping and follow-up. Am J Clin Pathol 121:679–687
22. Miyamoto H, Brimo F, Schultz L, Ye H, Miller JS, Fajardo DA, Lee TK, Epstein JI, Netto GJ (2010) Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Arch Pathol Lab Med 134:1160–1163. doi:10.1043/2009-0403-OA.1
23. Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR (2007) Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J Urol 178:1196–1200
24. Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM (2010) Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder. J Clin Pathol 63:910–915. doi:10.1136/jcp.2010.079764
25. Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q (2012) The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. PLoS One 7:e47199. doi:10.1371/journal.pone.0047199
26. Pellucchi F, Freschi M, Ibrahim B, Rocchini L, Maccagnano C, Briganti A, Rigatti P, Montorsi F, Colombo R (2011) Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. J Urol 186:2194–2199. doi:10.1016/j.juro.2011.07.070
27. Hansel DE, Miller JS, Cookson MS, Chang SS (2013) Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist. Urology 81:1123–1130. doi:10.1016/j.urology.2013.01.027
28. van Rhijn BW, van Leenders GJ, Ooms BC, Kirkels WJ, Zlotta AR, Boeve ER, Jöbsis AC, von der Kwast TH (2010) The pathologist’s mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur Urol 57:1052–1057. doi:10.1016/j.eururo.2009.09.022
29. Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T (2007) Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 78:338–344
30. Soloway MS, Bruck DS, Kim SS (2003) Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 170:438–441